Skip to main content
SpringerLink
Log in

Tobramycin dosage recommendation in patients with cystic fibrosis

  • Letter To The Editor
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marks, M. I. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J. Pediatr. 98 (1981) 173.

    Google Scholar 

  2. Nebcin manufacturers product information. Dista (1987).

  3. Siber, G. R., Echeverria, P., Smith, A. L., Paisley, J. W., Smith, D. H. Pharmacokinetics of gentamicin in children and adults. J. Infect. Dis. 132 (1975) 637.

    Google Scholar 

  4. Sendroy, J., Jr., Cecchini, L. P. Determination of human body surface area from height and weight. J. Appl. Physiol. 7 (1954) 1.

    Google Scholar 

  5. Weber, A., Smith, A. L., Opheim, K. E. Radioenzymatic assays for aminoglycosides with kanamycin 6′-acetyltransferase. J. Clin. Microbiol. 21 (1985) 419.

    Google Scholar 

  6. Hoff, S. E., Schiotz, P. O., Paulson, J. Tobramycin treatment ofPseudomonas aeruginosa infections in cystic fibrosis. Scand. J. Inf. Dis. 6 (1974) 337.

    Google Scholar 

  7. Kelly, H. B., Mendendez, R., Fan, L. Pharmacokinetics of tobramycin in cystic fibrosis. J. Pediatr. 100 (1982) 318.

    Google Scholar 

  8. Kearns, S. C., Hilman, B. C., Wilson, J. T. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. J. Pediatr. 100 (1982) 312.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Children's Hospital and Medical Center, 87131, Seattle, WA, USA

    R. L. Davis (Pharm. D.), P. Mendelman M.D., Bonnie Ramsey M.D. & A. L. Smith M.D.

  2. College of Pharmacy, the University of New Mexico, 87131, Albuquerque, NM, USA

    R. L. Davis (Pharm. D.), P. Mendelman M.D., Bonnie Ramsey M.D. & A. L. Smith M.D.

Authors
  1. R. L. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Mendelman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bonnie Ramsey M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. L. Smith M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, R.L., Mendelman, P., Ramsey, B. et al. Tobramycin dosage recommendation in patients with cystic fibrosis. Infection 17, 41 (1989). https://doi.org/10.1007/BF01643502

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01643502

Keywords

Search

Navigation